PATENT CLAIM ANALYSIS

Application Number: 15875369
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "152000"]

Abstract:
Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.

Claim (Index 43):
A method of treating inflammatory rosacea or an inflammatory symptom of either rosacea or acne vulgaris in a human patient in need thereof comprising administering a composition comprising:\n i. about 30 mg to less than about 50 mg of doxycycline, based on the equivalent weight of doxycycline base; ii. one or more water soluble and insoluble polymers; and iii. one or more pharmaceutically acceptable excipients; wherein said composition is free of any immediate release component; and wherein said composition has dC/dT value of less than about 80% of the dC/dT value provided by the commercially available 40 mg doxycycline composition, measured in a single dose human pharmacokinetic study in a fasting state and in a time period of T 0  min to T 60  mins.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 86.0
- Lexical Diversity: 1.51351
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15359292', '14946715', '14821263', '14882662', '14511420']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7200732039289283
- 35 USC 102 Novelty (BERT): 0.6147142724306369
- Combined Prediction Score: 0.7095373107790991
- Mean Citation Score: 385.43132
- Max Citation Score: 593.6012
- Similarity Product: 467.978624250102

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test